Search research articles
Contact Us
Filters
Showing results (11-20 of 43) with videos related to
Page
of 5
Sort By:
Leukemia Research Reports
|
March 9, 2026
Systemic, asymptomatic skeletal muscle infiltration by MALT lymphoma: Defining a 'silent infiltrator' phenotype with 18F-FDG PET/CT
Yasuyuki Takahashi, Ken Naganuma, Yuka Tanaka, et al.
Anticancer Research
|
March 9, 2012
Cytotoxicity of activated natural killer cells and expression of adhesion molecules in small-cell lung cancer
Tadashi Tsuchida, Hiromichi Yamane, Nobuaki Ochi, et al.
Internal Medicine (Tokyo, Japan)
|
November 17, 2012
Elevated coagulation factor VIII plasma activity in a patient with lymphangiosarcoma
Hiromichi Yamane, Nobuaki Ochi, Takayuki Tabayashi, et al.
British Journal of Haematology
|
September 27, 2003
The type 1 CD10/neutral endopeptidase 24.11 promoter: functional characterization of the 5'-untranslated region
Nobuo Sezaki, Fumihiko Ishimaru, Takayuki Tabayashi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
December 8, 2022
[Acute lymphoblastic leukemia with "masked" Philadelphia chromosome]
Ken Naganuma, Takayuki Tabayashi, Taisuke Kawada, et al.
British Journal of Haematology
|
April 3, 2003
Over-expression of the dominant-negative isoform of Ikaros confers resistance to dexamethasone-induced and anti-IgM-induced apoptosis
Nobuo Sezaki, Fumihiko Ishimaru, Minoru Takata, et al.
British Journal of Haematology
|
March 22, 2003
Over-expression of short isoforms of Helios in patients with adult T-cell leukaemia/lymphoma
Keiko Fujii, Fumihiko Ishimaru, Koichi Nakase, et al.
British Journal of Haematology
|
December 23, 2003
Elevation of serum hepatocyte growth factor during granulocyte colony-stimulating factor-induced peripheral blood stem cell mobilization
Keiko Fujii, Fumihiko Ishimaru, Teruhiko Kozuka, et al.
Cancer Science
|
December 19, 2019
Abemaciclib, a CDK4/6 inhibitor, exerts preclinical activity against aggressive germinal center-derived B-cell lymphomas
Yuka Tanaka, Shuji Momose, Takayuki Tabayashi, et al.
Cancer Science
|
January 24, 2015
TM-233, a novel analog of 1'-acetoxychavicol acetate, induces cell death in myeloma cells by inhibiting both JAK/STAT and proteasome activities
Morihiko Sagawa, Takayuki Tabayashi, Yuta Kimura, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 43) with videos related to
Sort By:
Page
of 5
Leukemia Research Reports
|
March 9, 2026
Systemic, asymptomatic skeletal muscle infiltration by MALT lymphoma: Defining a 'silent infiltrator' phenotype with 18F-FDG PET/CT
Yasuyuki Takahashi, Ken Naganuma, Yuka Tanaka, et al.
Anticancer Research
|
March 9, 2012
Cytotoxicity of activated natural killer cells and expression of adhesion molecules in small-cell lung cancer
Tadashi Tsuchida, Hiromichi Yamane, Nobuaki Ochi, et al.
Internal Medicine (Tokyo, Japan)
|
November 17, 2012
Elevated coagulation factor VIII plasma activity in a patient with lymphangiosarcoma
Hiromichi Yamane, Nobuaki Ochi, Takayuki Tabayashi, et al.
British Journal of Haematology
|
September 27, 2003
The type 1 CD10/neutral endopeptidase 24.11 promoter: functional characterization of the 5'-untranslated region
Nobuo Sezaki, Fumihiko Ishimaru, Takayuki Tabayashi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
December 8, 2022
[Acute lymphoblastic leukemia with "masked" Philadelphia chromosome]
Ken Naganuma, Takayuki Tabayashi, Taisuke Kawada, et al.
British Journal of Haematology
|
April 3, 2003
Over-expression of the dominant-negative isoform of Ikaros confers resistance to dexamethasone-induced and anti-IgM-induced apoptosis
Nobuo Sezaki, Fumihiko Ishimaru, Minoru Takata, et al.
British Journal of Haematology
|
March 22, 2003
Over-expression of short isoforms of Helios in patients with adult T-cell leukaemia/lymphoma
Keiko Fujii, Fumihiko Ishimaru, Koichi Nakase, et al.
British Journal of Haematology
|
December 23, 2003
Elevation of serum hepatocyte growth factor during granulocyte colony-stimulating factor-induced peripheral blood stem cell mobilization
Keiko Fujii, Fumihiko Ishimaru, Teruhiko Kozuka, et al.
Cancer Science
|
December 19, 2019
Abemaciclib, a CDK4/6 inhibitor, exerts preclinical activity against aggressive germinal center-derived B-cell lymphomas
Yuka Tanaka, Shuji Momose, Takayuki Tabayashi, et al.
Cancer Science
|
January 24, 2015
TM-233, a novel analog of 1'-acetoxychavicol acetate, induces cell death in myeloma cells by inhibiting both JAK/STAT and proteasome activities
Morihiko Sagawa, Takayuki Tabayashi, Yuta Kimura, et al.
Page
of 5